Search
Showing results for "Childhood interstitial lung disease "
Childhood mortality in low- or middle-income countries (LMICs) remains a major public health concern, with infections being a leading cause of infant death. Probiotics have shown promise in reducing infection-related morbidity and mortality in preterm infants, but their use in newborns born at or near term in LMICs requires further investigation.
identifying mechanisms of cancer development, generation of appropriate models of these diseases, evaluation of novel therapeutics and translation of discoveries into the clinic
The 2019 IIC Perth is a clinical training course in childhood infectious diseases, being held in Western Australia for a second time after the success of the first event in 2016.
We unite experts and communities to improve child health through research that has impact, using animals only when no other methods are suitable. We are also a signatory to the ANZCCART Animals in Research Openness Agreement.
Eight applicants were successful, and were awarded $15,000 each for activities supporting subsequent research grant applications.
The most urgent areas appear to be to continue monitoring the emergence of novel otopathogens, and the need to develop prevention and preventative therapies
The PCV7 was introduced to prevent IPD in WA Aboriginal people in 2001 to a lesser extent in older people.
Christopher Deborah Blyth Lehmann MBBS (Hons) DCH FRACP FRCPA PhD AO, MBBS, MSc Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases;
A register which stores demographic and clinical data on all patients attending the diabetes clinic at Princess Margaret Hospital
Accumulating evidence indicates that an early, robust type 1 interferon (IFN) response to SARS-CoV-2 is important in determining COVID-19 outcomes, with an inadequate IFN response associated with disease severity. Our objective was to examine the prophylactic potential of IFN administration to limit viral transmission.